Global Influenza Vaccination Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 156655
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 120
  • list Pharmaceuticals and Healthcare

Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, cough, sore throat, nasal congestion, and body aches. Influenza vaccine can prevent illness and death caused

Scope of the Report:

This report focuses on the Influenza Vaccination in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Stringent regulatory framework along with the low accessibility of the product in the developing countries may restrain the market growth.

The worldwide market for Influenza Vaccination is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Abbott (U.S.)

AstraZeneca (Europe)

BioCryst Pharmaceuticals, Inc. (U.S.)

Novartis AG (Europe)

DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific)

GlaxoSmithKline plc. (Europe)

Hualan Biological Engineering Inc (Asia Pacific)

Mitsubishi Tanabe Pharma Corporation (Asia Pacific)

F. Hoffmann-La Roche Ltd (Europe)

Sanofi (Europe)

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Egg Based

Cell Culture

Recombinant

Market Segment by Applications, can be divided into

Hospitals

Research Organizations

There are 15 Chapters to deeply display the global Influenza Vaccination market.

Chapter 1, to describe Influenza Vaccination Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Influenza Vaccination, with sales, revenue, and price of Influenza Vaccination, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Influenza Vaccination, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Influenza Vaccination market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Influenza Vaccination sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Influenza Vaccination Introduction

1.2 Market Analysis by Type

1.2.1 Egg Based

1.2.2 Cell Culture

1.2.3 Recombinant

1.3 Market Analysis by Applications

1.3.1 Hospitals

1.3.2 Research Organizations

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Abbott (U.S.)

2.1.1 Business Overview

2.1.2 Influenza Vaccination Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Abbott (U.S.) Influenza Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 AstraZeneca (Europe)

2.2.1 Business Overview

2.2.2 Influenza Vaccination Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 AstraZeneca (Europe) Influenza Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 BioCryst Pharmaceuticals, Inc. (U.S.)

2.3.1 Business Overview

2.3.2 Influenza Vaccination Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 BioCryst Pharmaceuticals, Inc. (U.S.) Influenza Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Novartis AG (Europe)

2.4.1 Business Overview

2.4.2 Influenza Vaccination Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Novartis AG (Europe) Influenza Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific)

2.5.1 Business Overview

2.5.2 Influenza Vaccination Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Influenza Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 GlaxoSmithKline plc. (Europe)

2.6.1 Business Overview

2.6.2 Influenza Vaccination Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 GlaxoSmithKline plc. (Europe) Influenza Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Hualan Biological Engineering Inc (Asia Pacific)

2.7.1 Business Overview

2.7.2 Influenza Vaccination Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Mitsubishi Tanabe Pharma Corporation (Asia Pacific)

2.8.1 Business Overview

2.8.2 Influenza Vaccination Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 F. Hoffmann-La Roche Ltd (Europe)

2.9.1 Business Overview

2.9.2 Influenza Vaccination Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 F. Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Sanofi (Europe)

2.10.1 Business Overview

2.10.2 Influenza Vaccination Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Sanofi (Europe) Influenza Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Influenza Vaccination Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Influenza Vaccination Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Influenza Vaccination Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Influenza Vaccination Manufacturer Market Share in 2017

3.3.2 Top 6 Influenza Vaccination Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Influenza Vaccination Market Analysis by Regions

4.1 Global Influenza Vaccination Sales, Revenue and Market Share by Regions

4.1.1 Global Influenza Vaccination Sales and Market Share by Regions (2013-2018)

4.1.2 Global Influenza Vaccination Revenue and Market Share by Regions (2013-2018)

4.2 North America Influenza Vaccination Sales and Growth Rate (2013-2018)

4.3 Europe Influenza Vaccination Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Influenza Vaccination Sales and Growth Rate (2013-2018)

4.5 South America Influenza Vaccination Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Influenza Vaccination Sales and Growth Rate (2013-2018)

5 North America Influenza Vaccination by Countries

5.1 North America Influenza Vaccination Sales, Revenue and Market Share by Countries

5.1.1 North America Influenza Vaccination Sales and Market Share by Countries (2013-2018)

5.1.2 North America Influenza Vaccination Revenue and Market Share by Countries (2013-2018)

5.2 United States Influenza Vaccination Sales and Growth Rate (2013-2018)

5.3 Canada Influenza Vaccination Sales and Growth Rate (2013-2018)

5.4 Mexico Influenza Vaccination Sales and Growth Rate (2013-2018)

6 Europe Influenza Vaccination by Countries

6.1 Europe Influenza Vaccination Sales, Revenue and Market Share by Countries

6.1.1 Europe Influenza Vaccination Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Influenza Vaccination Revenue and Market Share by Countries (2013-2018)

6.2 Germany Influenza Vaccination Sales and Growth Rate (2013-2018)

6.3 UK Influenza Vaccination Sales and Growth Rate (2013-2018)

6.4 France Influenza Vaccination Sales and Growth Rate (2013-2018)

6.5 Russia Influenza Vaccination Sales and Growth Rate (2013-2018)

6.6 Italy Influenza Vaccination Sales and Growth Rate (2013-2018)

7 Asia-Pacific Influenza Vaccination by Countries

7.1 Asia-Pacific Influenza Vaccination Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Influenza Vaccination Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Influenza Vaccination Revenue and Market Share by Countries (2013-2018)

7.2 China Influenza Vaccination Sales and Growth Rate (2013-2018)

7.3 Japan Influenza Vaccination Sales and Growth Rate (2013-2018)

7.4 Korea Influenza Vaccination Sales and Growth Rate (2013-2018)

7.5 India Influenza Vaccination Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Influenza Vaccination Sales and Growth Rate (2013-2018)

8 South America Influenza Vaccination by Countries

8.1 South America Influenza Vaccination Sales, Revenue and Market Share by Countries

8.1.1 South America Influenza Vaccination Sales and Market Share by Countries (2013-2018)

8.1.2 South America Influenza Vaccination Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Influenza Vaccination Sales and Growth Rate (2013-2018)

8.3 Argentina Influenza Vaccination Sales and Growth Rate (2013-2018)

8.4 Colombia Influenza Vaccination Sales and Growth Rate (2013-2018)

9 Middle East and Africa Influenza Vaccination by Countries

9.1 Middle East and Africa Influenza Vaccination Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Influenza Vaccination Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Influenza Vaccination Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Influenza Vaccination Sales and Growth Rate (2013-2018)

9.3 UAE Influenza Vaccination Sales and Growth Rate (2013-2018)

9.4 Egypt Influenza Vaccination Sales and Growth Rate (2013-2018)

9.5 Nigeria Influenza Vaccination Sales and Growth Rate (2013-2018)

9.6 South Africa Influenza Vaccination Sales and Growth Rate (2013-2018)

10 Global Influenza Vaccination Market Segment by Type

10.1 Global Influenza Vaccination Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Influenza Vaccination Sales and Market Share by Type (2013-2018)

10.1.2 Global Influenza Vaccination Revenue and Market Share by Type (2013-2018)

10.2 Egg Based Sales Growth and Price

10.2.1 Global Egg Based Sales Growth (2013-2018)

10.2.2 Global Egg Based Price (2013-2018)

10.3 Cell Culture Sales Growth and Price

10.3.1 Global Cell Culture Sales Growth (2013-2018)

10.3.2 Global Cell Culture Price (2013-2018)

10.4 Recombinant Sales Growth and Price

10.4.1 Global Recombinant Sales Growth (2013-2018)

10.4.2 Global Recombinant Price (2013-2018)

11 Global Influenza Vaccination Market Segment by Application

11.1 Global Influenza Vaccination Sales Market Share by Application (2013-2018)

11.2 Hospitals Sales Growth (2013-2018)

11.3 Research Organizations Sales Growth (2013-2018)

12 Influenza Vaccination Market Forecast (2018-2023)

12.1 Global Influenza Vaccination Sales, Revenue and Growth Rate (2018-2023)

12.2 Influenza Vaccination Market Forecast by Regions (2018-2023)

12.2.1 North America Influenza Vaccination Market Forecast (2018-2023)

12.2.2 Europe Influenza Vaccination Market Forecast (2018-2023)

12.2.3 Asia-Pacific Influenza Vaccination Market Forecast (2018-2023)

12.2.4 South America Influenza Vaccination Market Forecast (2018-2023)

12.2.5 Middle East and Africa Influenza Vaccination Market Forecast (2018-2023)

12.3 Influenza Vaccination Market Forecast by Type (2018-2023)

12.3.1 Global Influenza Vaccination Sales Forecast by Type (2018-2023)

12.3.2 Global Influenza Vaccination Market Share Forecast by Type (2018-2023)

12.4 Influenza Vaccination Market Forecast by Application (2018-2023)

12.4.1 Global Influenza Vaccination Sales Forecast by Application (2018-2023)

12.4.2 Global Influenza Vaccination Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Influenza Vaccination Picture

Table Product Specifications of Influenza Vaccination

Figure Global Sales Market Share of Influenza Vaccination by Types in 2017

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery